Connection

Dariusz Dudek to Risk Factors

Back to Details
This is a "connection" page, showing publications Dariusz Dudek has written about Risk Factors.
Dariusz Dudek
Connection Strength
0.410
Risk Factors
  1. The beginning of a new era in the field of percutaneous valvular interventions (PARTNER 3 and Evolut Low Risk trials). Cardiovasc Res. 2019 Sep 01; 115(11):e105-e106.
    View in: PubMed
    Score: 0.025
  2. Characteristics of patients presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA) in Poland: data from the ORPKI national registry. J Thromb Thrombolysis. 2019 Apr; 47(3):462-466.
    View in: PubMed
    Score: 0.024
  3. Impact of sex on the follow-up course and predictors of clinical outcomes in patients hospitalised due to myocardial infarction with non-obstructive coronary arteries: a single-centre experience. Kardiol Pol. 2019; 77(2):198-206.
    View in: PubMed
    Score: 0.024
  4. Clinical outcomes in nonagenarians undergoing a percutaneous coronary intervention: data from the ORPKI Polish National Registry 2014-2016. Coron Artery Dis. 2018 11; 29(7):573-578.
    View in: PubMed
    Score: 0.024
  5. Psoriasis is an independent predictor of increased risk of allergic reaction during percutaneous coronary interventions. Big data analysis from the Polish National PCI Registry (ORPKI). Cardiol J. 2020; 27(3):278-284.
    View in: PubMed
    Score: 0.023
  6. Impact of On-Site Surgical Backup on Periprocedural Outcomes of Primary Percutaneous Interventions in Patients Presenting With ST-Segment Elevation Myocardial Infarction (From the ORPKI Polish National Registry). Am J Cardiol. 2018 09 15; 122(6):929-935.
    View in: PubMed
    Score: 0.023
  7. Usefulness of Psoas Muscle Area and Volume and Frailty Scoring to Predict Outcomes After Transcatheter Aortic Valve Implantation. Am J Cardiol. 2018 07 01; 122(1):135-140.
    View in: PubMed
    Score: 0.023
  8. Impact of chronic obstructive pulmonary disease and frailty on long-term outcomes and quality of life after transcatheter aortic valve implantation. Aging Clin Exp Res. 2018 Sep; 30(9):1033-1040.
    View in: PubMed
    Score: 0.022
  9. An optical coherence tomography study of neointimal morphology and strut coverage at different time intervals from implantation of biodegradable polymer-coated sirolimus-eluting stents. Catheter Cardiovasc Interv. 2018 08 01; 92(2):302-309.
    View in: PubMed
    Score: 0.022
  10. Reduced periprocedural mortality and bleeding rates of radial approach in ST-segment elevation myocardial infarction. Propensity score analysis of data from the ORPKI Polish National Registry. EuroIntervention. 2017 Sep 20; 13(7):843-850.
    View in: PubMed
    Score: 0.022
  11. Effect of diabetes mellitus on clinical outcomes and quality of life after transcatheter aortic valve implantation for severe aortic valve stenosis. Hellenic J Cardiol. 2018 Mar - Apr; 59(2):100-107.
    View in: PubMed
    Score: 0.022
  12. Incidence of Postoperative Delirium and Its Impact on Outcomes After Transcatheter Aortic Valve Implantation. Am J Cardiol. 2017 Oct 01; 120(7):1187-1192.
    View in: PubMed
    Score: 0.022
  13. Prognostic value of tricuspid regurgitation velocity and probability of pulmonary hypertension in patients undergoing transcatheter aortic valve implantation. Int J Cardiovasc Imaging. 2017 Dec; 33(12):1931-1938.
    View in: PubMed
    Score: 0.022
  14. Sex-Related Differences in Outcomes After Percutaneous Balloon Aortic Valvuloplasty. J Invasive Cardiol. 2017 Jun; 29(6):188-194.
    View in: PubMed
    Score: 0.022
  15. Recanalization of peripheral arteries by interventional cardiologists: rationale and results. Int J Cardiol. 2008 Sep 26; 129(2):304-6.
    View in: PubMed
    Score: 0.011
  16. Body mass index and long-term outcomes in patients with chronic total occlusions undergoing retrograde endovascular revascularization of the infra-inguinal lower limb arteries. Cardiol J. 2021; 28(4):509-518.
    View in: PubMed
    Score: 0.006
  17. Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial. Cardiovasc Revasc Med. 2019 Jul; 20(7):577-582.
    View in: PubMed
    Score: 0.006
  18. Impact of Coronary Artery Disease and Diabetes Mellitus on the Long-Term Follow-Up in Patients after Retrograde Recanalization of the Femoropopliteal Arterial Region. J Diabetes Res. 2019; 2019:6036359.
    View in: PubMed
    Score: 0.006
  19. The obesity paradox in patients undergoing transcatheter aortic valve implantation: is there any effect of body mass index on survival? Kardiol Pol. 2019; 77(2):190-197.
    View in: PubMed
    Score: 0.006
  20. Prevalence and clinical presentation of myocardial bridge on the basis of the National Polish Percutaneous Interventions Registry and the Classification of Rare Cardiovascular Diseases. Kardiol Pol. 2018 Dec 20; 77(4):465-470.
    View in: PubMed
    Score: 0.006
  21. Chronic obstructive pulmonary disease and periprocedural complications in patients undergoing percutaneous coronary interventions. PLoS One. 2018; 13(10):e0204257.
    View in: PubMed
    Score: 0.006
  22. Left-Sided Atrial Septal Pouch is a Risk Factor for Cryptogenic Stroke. J Am Soc Echocardiogr. 2018 07; 31(7):771-776.
    View in: PubMed
    Score: 0.006
  23. Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial). EuroIntervention. 2018 01 20; 13(13):1561-1564.
    View in: PubMed
    Score: 0.006
  24. Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry. JACC Cardiovasc Interv. 2017 12 26; 10(24):2548-2556.
    View in: PubMed
    Score: 0.006
  25. Predictors of in-hospital effectiveness and complications of rotational atherectomy (from the ORPKI Polish National Registry 2014-2016). Catheter Cardiovasc Interv. 2018 10 01; 92(4):E278-E287.
    View in: PubMed
    Score: 0.006
  26. Comparative assessment of three drug eluting stents with different platforms but with the same biodegradable polymer and the drug based on quantitative coronary angiography and optical coherence tomography at 12-month follow-up. Int J Cardiovasc Imaging. 2018 Mar; 34(3):353-365.
    View in: PubMed
    Score: 0.006
  27. SYNTAX Score and Pre- and Poststent Optical Coherence Tomography Findings in the Left Anterior Descending Coronary Artery in Patients With Stable Angina Pectoris. Am J Cardiol. 2017 Sep 15; 120(6):898-903.
    View in: PubMed
    Score: 0.005
  28. Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes. JACC Cardiovasc Imaging. 2012 Mar; 5(3 Suppl):S42-52.
    View in: PubMed
    Score: 0.004
  29. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation. 2011 Apr 26; 123(16):1745-56.
    View in: PubMed
    Score: 0.004
  30. Coronary microcirculation and reperfusion failure. Do we know what diagnostic tools we have? Przegl Lek. 2002; 59(11):932-40.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.